Gefitinib plus Fuzheng Kang'ai Formula (扶正抗癌方) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a …
X Yang, X Chai, W Wu, S Long, H Deng, Z Pan… - Chinese journal of …, 2018 - Springer
… Effectiveness of traditional Chinese medicine for liver protection and chemotherapy completion
among cancer … Randomized phase Ⅱ study of erlotinib plus tivantinib versus erlotinib …
among cancer … Randomized phase Ⅱ study of erlotinib plus tivantinib versus erlotinib …
[HTML][HTML] 吉非替尼联合化疗治疗50 例晚期非小细胞肺癌患者的疗效
王建丽， 王筱静， 孙玉莲， 胡晓乐… - 山东大学学报(医学 …, 2022 - yxbwk.njournal.sdu.edu.cn
… Efficacy of erlotinib in treatment of end-stage non-small cell … Efficacy and safety of gefitinib
or docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer…
or docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer…
贝伐单抗治疗晚期非小细胞肺癌的疗效与安全性临床研究进展
胡彬彬， 陈宝清， 卢铀 - 中国肿瘤临床, 2017 - cjco.cn
… -line treatment of advanced non-small cell lung cancer (NSCLC… -line treatment of NSCLC
and evaluate its efficacy and safety … Erlotinib in previously treated non-small cell lung cancer[J]. …
and evaluate its efficacy and safety … Erlotinib in previously treated non-small cell lung cancer[J]. …
EGFR-TKIs 一线治疗晚期非小细胞肺癌的有效性和安全性比较: 网状Meta 分析
张慧芳， 马金沙， 李璐， 高倩， 王彤 - 中华疾病控制杂志, 2020 - zhjbkz.ahmu.edu.cn
… 小细胞肺癌(non-small cell lung cancer, NSCLC)的有效性和安全性. … efficacy and safety of
gefitinib, erlotinib, and afatinib in the first-line treatment of advanced non-small cell lung cancer(…
gefitinib, erlotinib, and afatinib in the first-line treatment of advanced non-small cell lung cancer(…
表皮生长因子受体酪氨酸激酶抑制剂在野生型进展期非小细胞肺癌治疗中的地位
辛田， 马锐 - 循证医学, 2014 - jebm.cn
… non-small cell lung cancer,NSCLC)的治疗 进入了分子靶向治疗时代. 早期的一些Ⅱ期研究 中
,吉非替尼(Gefitinib) /厄洛替尼(Erlotinib… Efficacy and safety of Erlotinib versus chemotherapy in …
,吉非替尼(Gefitinib) /厄洛替尼(Erlotinib… Efficacy and safety of Erlotinib versus chemotherapy in …
[PDF][PDF] 厄洛替尼治疗晚期非小细胞肺癌的临床研究
王同杉， 孙婧， 高雯， 沈华， 李晓东， 殷咏梅， 束永前… - 2009 - scholar.archive.org
… and objective Erlotinib has been used widely in non-small cell lung cancer (NSCLC), and a
… on the efficacy and safety of erlotinib in treatment of advanced non-small cell lung cancer. …
… on the efficacy and safety of erlotinib in treatment of advanced non-small cell lung cancer. …
[PDF][PDF] 厄洛替尼治疗晚期非小细胞肺癌92 例临床观察
顾爱琴， 熊丽纹， 王慧敏， 施春雷， 高志强， 韩宝惠 - 2009 - scholar.archive.org
… [Abstract] Background and objective Erlotinib, a … metastatic non-small cell lung cancer (NSCLC).
The aim of this study was to evaluate the efficacy and safety of erlotinib for the treatment …
The aim of this study was to evaluate the efficacy and safety of erlotinib for the treatment …
厄洛替尼二次治疗晚期非小细胞肺癌患者的临床分析
吴标， 黄诚， 蒋侃 - 中国癌症杂志, 2015 - china-oncology.com
… erlotinib on treatment of patients with epidermal growth factor receptor mutation in advanced
non-small cell lung cancer (… to evaluate the efficacy and safety of retreatment of erlotinib in …
non-small cell lung cancer (… to evaluate the efficacy and safety of retreatment of erlotinib in …
[PDF][PDF] 晚期非小细胞肺癌的二线治疗进展
张力 - 2008 - scholar.archive.org
… chemotherapy in advanced non-small cell lung cancer (NSCLC), … Gefitinib and erlotinib
monotherapy have a good efficacy in … Safety of erlotinib in TRUST, a phase IV trial in patients with …
monotherapy have a good efficacy in … Safety of erlotinib in TRUST, a phase IV trial in patients with …